In this trial of 300 non-ICU patients admitted with CAP, they were randomized to steroids (dexa 5mg IV qday for 4 days) or placebo. Although the steroids patients had 1 day shorter length of stay, they were significantly more likely to be hyperglycemic. The risks and benefits are not yet clear enough to routinely recommend this in hospitalized CAP patients (abstract)
Dr. Scheurer is a clinical hospitalist and the Medical Director of Quality and Safety at the Medical University of South Carolina in Charleston, South Carolina, and is Assistant Professor of Medicine. She is a graduate of the University of Tennessee College of Medicine, completed her residency at Duke University, and completed her Masters in Clinical Research at the Medical University of South Carolina. She also serves as the Web Editor and Physician Advisor for the Society of Hospital Medicine.